CPT1A and metabolic syndrome: The impairment of a rate-limiting FA oxidation enzyme, carnitine palmitoyltransferase 1 (CPT1), and a rate-limiting TG hydrolysis enzyme, lipoprotein lipase (LPL), is also important mechanism in the development of hepatic lipid accumulation and dyslipidemia [6,7].